Fusion IP Diurnal's key drug moves to Phase II trials Proactive Investors USA & Canada Victims of adrenal insufficiency, for example, cannot produce enough cortisol, an essential stress hormone, and must administer hydrocortisone in its place. |
Fusion IP Diurnal's key drug moves to Phase II trials Proactive Investors USA & Canada Victims of adrenal insufficiency, for example, cannot produce enough cortisol, an essential stress hormone, and must administer hydrocortisone in its place. |